Results 101 to 110 of about 20,462 (241)
Eye and Brain, 2017 Heather E Moss1,2 1Department of Ophthalmology, Stanford University, Palo Alto, CA, USA; 2Department of Neurology & Neuroscience, Stanford University, Stanford, CA, USA Abstract: Multiple sclerosis (MS) is associated with vision changes both due to ...
Moss HE
doaj
A Case of Progressive Multifocal Leukoencephalopathy in a 10-year-old Girl [PDF]
, 2015 최미란, 권영세, 강빈
openalex +1 more source
Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome [PDF]
, 2017 Progressive multi-focal leucoencephalopathy and progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome are caused by infection of the central nervous system with the JC polyoma virus.
Aly, Lilian +15 more
core
Relapsing-remitting multiple sclerosis: advances in disease-modifying therapies [PDF]
, 2015 Multiple sclerosis is a demyelinating disease affecting the central nervous system. It is the most prevalent disabling neurological condition among young adults, with onset typically between 20 and 40 years of age. Infiltrating immune cells and microglia
Kay, Kathleen Alexandra
core +1 more source
A Representative Survey of M.S. Patients on Attitudes toward the Benefits and Risks of Drug Therapy [PDF]
, 2006 Background: Although M.S. patients face significant trade-offs between risks and benefits of drug therapy, little is known of their attitudes toward these risks and benefits.
John E. Calfee
core
spectrum of acquired demyelinating disorders of the central nervous system in adults in a tertiary care hospital [PDF]
, 2014 Acquired demyelinating disorders of the central nervous system are diverse group of conditions characterized by destruction or disturbance of myelin sheath in the central nervous system i.e. brain and spinal cord.
Alam, Dr Naveed +3 more
core +1 more source
A Representative Survey of M.S. Patients on Attitudes toward the Benefits and Risks of Drug Therapy [PDF]
Background: Although M.S. patients face significant trade-offs between risks and benefits of drug therapy, little is known of their attitudes toward these risks and benefits.
Calfee, John E.
core +1 more source
Progressive multifocal leukoencephalopathy in a patient with multiple myeloma [PDF]
, 2010 Masaru Akiyama +4 more
openalex +1 more source